Iradimed Corp (IRMD)
| Market Cap | 1.08B+10.2% |
| Revenue (ttm) | 86.34M |
| Net Income | 23.05M |
| EPS | 1.79 |
| Shares Out | 12.79M |
| PE Ratio | 47.31 |
| Forward PE | 34.52 |
| Dividend | $0.80(0.94%) |
| Ex-Dividend Date | Aug 14, 2026 |
| Volume | 9,774 |
| Open | 85.59 |
| Previous Close | 85.47 |
| Day's Range | 84.68 - 85.59 |
| 52-Week Range | 71.34 - 107.90 |
| Beta | 0.91 |
| Analysts | none |
| Price Target | 118.00(+39.35%) |
| Earnings Date | Nov 3, 2026 |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$IRMD stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in IRMD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IRMD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IRMD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New IRMD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IRMD from public contracts
Source: USAspending.gov
IRMD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from IRMD’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score